SynthesisMedicine2019

Combination strategies based on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for cancer patients: Pooled analysis and subgroup analysis of efficacy and safety.

Ran Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.